Document is current
Any future updates will be listed below
-
Authors
Kivelä, Laura
Caminero, Alberto https://orcid.org/0000-0001-9555-7167
Leffler, Daniel A.
Pinto-Sanchez, Maria Ines https://orcid.org/0000-0002-9040-9824
Tye-Din, Jason A. https://orcid.org/0000-0001-7687-9654
Lindfors, Katri https://orcid.org/0000-0001-7417-5151
- License Information
-
More Information
Article History
Accepted: 19 October 2020
First Online: 20 November 2020
Competing interests
: L.K. reports personal fees for lectures from the Finnish Coeliac Society outside the submitted work and participation in the AMG 714 trial. D.A.L. is the Medical Director for Takeda Pharmaceuticals. J.T.-D. is an inventor of patents pertaining to the use of gluten-derived T cell epitopes for use in coeliac disease therapeutics and was an investigator in the Nexvax2 phase II trial. The other authors declare no competing interests.
